David Bailey
Stock Analyst at Morgan Stanley
(3.98)
# 1,786
Out of 5,081 analysts
232
Total ratings
49.2%
Success rate
8.9%
Average return
Main Sectors:
Stocks Rated by David Bailey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CSL CSL Limited | Reiterated: Buy | $200.00 | $194.84 | +2.65% | 36 | Oct 23, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Hold | n/a | $35.77 | - | 32 | Oct 22, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Hold | $133.00 | $138.93 | -4.27% | 18 | Oct 1, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $23.90 | $12.75 | +87.45% | 18 | Sep 15, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.70 | $2.10 | +76.61% | 7 | Sep 8, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Sell | $40.90 → $41.90 | $54.95 | -23.75% | 38 | Sep 3, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Sell | $20.60 → $20.30 | $19.01 | +6.79% | 21 | Sep 1, 2026 | |
| ASX: ANN Ansell Limited | Reiterated: Hold | $32.70 → $37.90 | $46.15 | -17.87% | 17 | Aug 31, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Reiterated: Buy | n/a | $48.30 | - | 11 | Aug 24, 2026 | |
| RMD ResMed | Reiterated: Hold | $230 | $253.20 | -9.16% | 17 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $127.50 → $152.50 | $198.49 | n/a | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.50 → $1.35 | $0.44 | n/a | 6 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.05 → $3.55 | $4.77 | n/a | 5 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.30 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.36 | $2.42 | n/a | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.75 | $0.86 | n/a | 1 | Jan 21, 2021 |
CSL Limited
Oct 23, 2026
Reiterated: Buy
Price Target: $200.00
Current: $194.84
Upside: +2.65%
ResMed Inc.
Oct 22, 2026
Reiterated: Hold
Price Target: n/a
Current: $35.77
Upside: -
Cochlear Limited
Oct 1, 2026
Reiterated: Hold
Price Target: $133.00
Current: $138.93
Upside: -4.27%
Telix Pharmaceuticals Limited
Sep 15, 2026
Reiterated: Buy
Price Target: $23.90
Current: $12.75
Upside: +87.45%
Integral Diagnostics Limited
Sep 8, 2026
Reiterated: Buy
Price Target: $3.70
Current: $2.10
Upside: +76.61%
Ramsay Health Care Limited
Sep 3, 2026
Reiterated: Sell
Price Target: $40.90 → $41.90
Current: $54.95
Upside: -23.75%
Sonic Healthcare Limited
Sep 1, 2026
Reiterated: Sell
Price Target: $20.60 → $20.30
Current: $19.01
Upside: +6.79%
Ansell Limited
Aug 31, 2026
Reiterated: Hold
Price Target: $32.70 → $37.90
Current: $46.15
Upside: -17.87%
Fisher & Paykel Healthcare Corporation Limited
Aug 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $48.30
Upside: -
ResMed
Jul 13, 2026
Reiterated: Hold
Price Target: $230
Current: $253.20
Upside: -9.16%
Aug 15, 2024
Reiterated: Buy
Price Target: $127.50 → $152.50
Current: $198.49
Upside: n/a
Feb 28, 2024
Reiterated: Hold
Price Target: $1.50 → $1.35
Current: $0.44
Upside: n/a
Jan 31, 2024
Reiterated: Buy
Price Target: $3.05 → $3.55
Current: $4.77
Upside: n/a
Aug 24, 2021
Reiterated: Hold
Price Target: n/a
Current: $13.30
Upside: n/a
Jan 21, 2021
Reiterated: Hold
Price Target: $0.36
Current: $2.42
Upside: n/a
Jan 21, 2021
Downgraded: Hold
Price Target: $2.75
Current: $0.86
Upside: n/a